🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Arthroscopic Stabilization of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss

RecruitingNAAges 18 Years - anyAllClinique Générale dAnnecy
NCT07715162 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Recurrent anterior shoulder instability is a common condition among young and active patients, with a significant impact on function and a high risk of recurrence in the absence of appropriate management. Quantifying glenoid bone loss has become a central component of the treatment strategy, with losses exceeding 20 % traditionally considered critical and requiring a coracoid transfer according to the Latarjet procedure. Recent data have, however, shown that so-called "subcritical" bone loss, ranging from 13.5 to 20%, may already be associated with unfavorable clinical outcomes, particularly in highly active patients. These patients most often present with associated humeral lesions, such as Hill-Sachs lesions, and sometimes other concomitant lesions such as Humeral Avulsion of the Glenohumeral Ligament, underscoring the need for a comprehensive therapeutic approach. Two arthroscopic te

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * aged 18 or older * with symptomatic recurrent anterior shoulder instability indicating the need for surgical stabilization * whose glenoid bone loss must be classified as subcritical, approximately between 13.5% and 20%, according to the criteria defined in the protocol * with HAGL lesions * with bone lesions * capable of providing informed consent and complying with the planned 24-month follow-up Exclusion Criteria: * with glenoid bone loss exceeding 20% * with a clear indication for another procedure not covered by the protocol (particularly if routine bone grafting is required and incompatible with the study) * with a history of bone stabilization of the affected shoulder * with a transfixing rotator cuff tear or a neurological condition impairing shoulder function * unable to guarantee adequate follow-up * under legal guardianship (curatorship, guardianship, or judicial protection) * deprived of liberty by judicial or administrative order * receiving psychiatric care * not enrolled in a social security program
💊

What it tests

  • Arthroscopic Latarjet procedure
  • Dynamic anterior stabilization (DAS)
📍

Where

1 site
Clinique Générale d'Annecy
Annecy, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy